Enterprise Value
37.44M
Cash
153.6M
Avg Qtr Burn
-53.29M
Short % of Float
15.75%
Insider Ownership
2.58%
Institutional Own.
-
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Tab-cel (tabelecleucel) Details Viral infection, Epstein-Barr virus, Nasopharyngeal carcinoma, Solid organ transplant, Hematopoietic cell transplantation | Phase 2 Data readout | |
ATA188 Details Multiple sclerosis, Epstein-Barr virus | Phase 2 Update | |
ATA3219 Details Non-Hodgkin lymphoma, Blood cancer, Cancer | Phase 1 Initiation |